COMPARISON OF THROMBOLYTIC AGENTS - SELECTED HEMATOLOGIC, VASCULAR AND CLINICAL EVENTS

被引：9
|
作者：
MARDER, VJ
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1989年 / 64卷 / 02期
关键词：
D O I：
10.1016/0002-9149(89)90921-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A2 / A7
页数：6
相关论文
共 50 条
  • [21] Clinical and economic outcomes in the thrombolytic treatment of peripheral vascular occlusion.
    Kaul, AF
    Leonard, MC
    Ouriel, K
    Katzen, TB
    PHARMACOTHERAPY, 2003, 23 (10): : 1356 - 1356
  • [22] FIBRINOLYTIC RESPONSE OF CULTURED VASCULAR ENDOTHELIAL-CELLS INDUCED BY ADDITION OF THROMBOLYTIC AGENTS
    AWAYA, T
    NAKAZAWA, A
    HATTORI, A
    SUZUKI, T
    MIYAKE, F
    KAMOGAWA, A
    KANDA, H
    AKASHI, K
    MURAYAMA, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A14 - A14
  • [23] Comparison of hemostatic agents used in vascular surgery
    Vyas, Krishna S.
    Saha, Sibu P.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (12) : 1663 - 1672
  • [24] THROMBOLYTIC THERAPY - AGENTS, INDICATION, CLINICAL-PERFORMANCE, AND SIDE-EFFECTS
    TILSNER, V
    GREUL, W
    VASCULAR SURGERY, 1979, 13 (02): : 79 - 86
  • [25] INTRAARTERIAL FIBRINOLYSIS - INVITRO AND PROSPECTIVE CLINICAL-EVALUATION OF 3 THROMBOLYTIC AGENTS
    PILGER, E
    LAMMER, J
    BERTUCH, H
    STEINER, H
    RADIOLOGY, 1986, 161 (03) : 597 - 599
  • [26] Pharmacokinetics of the recombinant thrombolytic agents - What is the clinical significance of their different pharmacokinetic parameters?
    Cohen, A
    BIODRUGS, 1999, 11 (02) : 115 - 123
  • [27] REVIEW OF CLINICAL-STUDIES OF THROMBOLYTIC AGENTS IN ACUTE MYOCARDIAL-INFARCTION
    SCHREIBER, T
    AMERICAN JOURNAL OF MEDICINE, 1987, 83 (2A): : 20 - 25
  • [28] USE OF SELECTED CLINICAL AND HEMATOLOGIC CRITERIA FOR DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    BITTER, T
    FRIOU, GJ
    DUBOIS, EL
    ARTHRITIS AND RHEUMATISM, 1970, 13 (03): : 308 - &
  • [29] Comparison of two thrombolytic agents (reteplase vs alteplase) in the treatment of acute myocardial infarction
    Eleftheriadis, D
    Fourla, E
    Vrizidis, P
    Fourlas, C
    Eleftheriadis, N
    Pistevou-Gompaki, K
    CARDIOVASCULAR DIESEASES 2002, 2002, : 181 - 183
  • [30] A THROMBOSIS MODEL FOR EVALUATING THROMBOLYTIC AGENTS IN THE GUINEA-PIG - COMPARISON OF T-PA, SCU-PA AND A NOVEL THROMBOLYTIC AGENT, STAPHYLOKINASE, ON THROMBOLYTIC ACTIVITY
    HIRATA, Y
    UMEMURA, K
    TAKIGUCHI, Y
    UEMATSU, T
    NAKASHIMA, M
    BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (04) : 569 - 575
12345